In the Leloir pathway, galactose is initially converted to galactose-1-phosphate by galactokinase (GALK1), which allows cancer cells to utilize galactose as an alternative fuel source instead of glucose in glioblastoma (GBM) [29]. Here, GALK1 is linked to cancer.